Uploaded July 2025 | Updated September 2026, 3 weeks ago
Chronic diseases like asthma, cancer, and COPD impact millions worldwide—and the tissue damage they cause is often difficult to treat, let alone reverse. Gaining insight into how these diseases develop and progress requires examining changes at the microscopic level.
At Carleton University’s Tissue Engineering and BioImaging Lab, Professor Leila Mostaço-Guidolin and her team of graduate students are combining advanced imaging, microscopy, and 3D bioprinting to study how chronic diseases alter tissue—and explore ways to repair, regenerate, or develop entirely new therapies.
Working alongside clinicians and researchers at the Ottawa Hospital Research Institute and the University of Ottawa Heart Institute, their discoveries are helping transform how we diagnose and treat chronic illness.
Learn more: teb-lab.com
------------------------------------------------------------------------
Visit Carleton University at https://carleton.ca.
Chronic diseases like asthma, cancer, and COPD impact millions worldwide—and the tissue damage they cause is often difficult to treat, let alone reverse. Gaining insight into how these diseases develop and progress requires examining changes at the microscopic level.
At Carleton University’s Tissue Engineering and BioImaging Lab, Professor Leila Mostaço-Guidolin and her team of graduate students are combining advanced imaging, microscopy, and 3D bioprinting to study how chronic diseases alter tissue—and explore ways to repair, regenerate, or develop entirely new therapies.
Working alongside clinicians and researchers at the Ottawa Hospital Research Institute and the University of Ottawa Heart Institute, their discoveries are helping transform how we diagnose and treat chronic illness.
Learn more: teb-lab.com
------------------------------------------------------------------------
Visit Carleton University at https://carleton.ca.
